What does GOVEMED do?

GOVEMED is filed with the CBE under the catch-all “Overige zakelijke dienstverlening”, a code that says little about what the company actually does. Private Limited, started on 4 September 2007, 1 establishment.

What is the address of GOVEMED?

The registered office of GOVEMED is located at Kroonplein 46, 2170 Antwerpen.

Is GOVEMED still active?

Yes. According to the CBE (7 October 2026) GOVEMED is active, legal situation “Normale toestand”, started on 4 September 2007.

Is GOVEMED registered on Peppol?

Yes, GOVEMED is registered on the Peppol network with ID 0208:0892125430.

What is the enterprise number of GOVEMED?

The enterprise number of GOVEMED is BE0892125430.

When was GOVEMED founded?

GOVEMED was founded on 4 September 2007.

Who are the directors of GOVEMED?

According to the 2025 annual accounts, the directors of GOVEMED are: Victor Gortz.

Is GOVEMED a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 September 2007; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did GOVEMED make in 2025?

GOVEMED posted a profit after taxes of € 48,302 in financial year 2025.

What is the revenue of GOVEMED?

As a small company, GOVEMED is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 121,979.

GOVEMED (Private Limited) - Antwerpen - BE0892125430

Dossier GOVEMED, printed on 7 October 2026 from databakkes.be/en/0892125430/govemed. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 13 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

GOVEMED from Antwerpen, company number BE0892125430, closed financial year 2025 with a result of € 48,302 after tax. For that financial year GOVEMED recorded a gross margin of € 121,979 and equity of € 2.1 million. Compared with financial year 2024, the result moved from € 46,431 to € 48,302. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 9, 2025.

What it is worth Growing

€ 2.1 million

▲ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 48,302

▲ 4% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 2,211

▼ 77% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 612,386.

People and assets in 2025

Vehicles and equipment

€ 4,432

▼ 65% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 12 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 597,993

▼ 7% vs 2024

€ 48,583 is repaid this year. At this pace the long-term loan is gone in ≈ 12 years.

Owed to suppliers

€ 4,795

▼ 63% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3,219

▼ 48% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 84,383 Gross margin 2022: € 84,383 First fiscal year in the series	€ 114,656 Gross margin 2023: € 114,656 ▲ 36% vs 2022 (€ 84,383) Favourable step	€ 112,323 Gross margin 2024: € 112,323 ▼ 2% vs 2023 (€ 114,656) Unfavourable step	€ 121,979 Gross margin 2025: € 121,979 ▲ 9% vs 2024 (€ 112,323) Favourable step	▲ 9%
Profit after taxes	€ 50,170 Profit after taxes 2022: € 50,170 First fiscal year in the series	€ 14,646 Profit after taxes 2023: € 14,646 ▼ 71% vs 2022 (€ 50,170) Unfavourable step	€ 46,431 Profit after taxes 2024: € 46,431 ▲ 217% vs 2023 (€ 14,646) Favourable step	€ 48,302 Profit after taxes 2025: € 48,302 ▲ 4% vs 2024 (€ 46,431) Favourable step	▲ 4%
Equity	€ 1,968,007 Equity 2022: € 1,968,007 First fiscal year in the series	€ 1,982,653 Equity 2023: € 1,982,653 ▲ 1% vs 2022 (€ 1,968,007) Favourable step	€ 2,029,084 Equity 2024: € 2,029,084 ▲ 2% vs 2023 (€ 1,982,653) Favourable step	€ 2,077,386 Equity 2025: € 2,077,386 ▲ 2% vs 2024 (€ 2,029,084) Favourable step	▲ 2%
Total debts	€ 572,909 Total debts 2022: € 572,909 First fiscal year in the series	€ 1,081,908 Total debts 2023: € 1,081,908 ▲ 89% vs 2022 (€ 572,909) Unfavourable step	€ 1,012,720 Total debts 2024: € 1,012,720 ▼ 6% vs 2023 (€ 1,081,908) Favourable step	€ 931,799 Total debts 2025: € 931,799 ▼ 8% vs 2024 (€ 1,012,720) Favourable step	▼ 8%
Cash	€ 1,510 Cash 2022: € 1,510 First fiscal year in the series	€ 32 Cash 2023: € 32 ▼ 98% vs 2022 (€ 1,510) Unfavourable step	€ 9,526 Cash 2024: € 9,526 ▲ € 9,494 vs 2023 (€ 32) Favourable step	€ 2,211 Cash 2025: € 2,211 ▼ 77% vs 2024 (€ 9,526) Unfavourable step	▼ 77%
Land & buildings	-	€ 555,342 Land & buildings 2023: € 555,342 First fiscal year in the series	€ 544,114 Land & buildings 2024: € 544,114 ▼ 2% vs 2023 (€ 555,342) Unchanged	€ 529,786 Land & buildings 2025: € 529,786 ▼ 3% vs 2024 (€ 544,114) Unchanged	▼ 3%
Retained profit	€ 503,007 Retained profit 2022: € 503,007 First fiscal year in the series	€ 517,653 Retained profit 2023: € 517,653 ▲ 3% vs 2022 (€ 503,007) Favourable step	€ 564,084 Retained profit 2024: € 564,084 ▲ 9% vs 2023 (€ 517,653) Favourable step	€ 612,386 Retained profit 2025: € 612,386 ▲ 9% vs 2024 (€ 564,084) Favourable step	▲ 9%
Bank debt	€ 202,252 Bank debt 2022: € 202,252 First fiscal year in the series	€ 708,180 Bank debt 2023: € 708,180 ▲ 250% vs 2022 (€ 202,252) Unfavourable step	€ 642,693 Bank debt 2024: € 642,693 ▼ 9% vs 2023 (€ 708,180) Favourable step	€ 597,993 Bank debt 2025: € 597,993 ▼ 7% vs 2024 (€ 642,693) Favourable step	▼ 7%
Balance sheet total	€ 2,540,916 Balance sheet total 2022: € 2,540,916 First fiscal year in the series	€ 3,064,561 Balance sheet total 2023: € 3,064,561 ▲ 21% vs 2022 (€ 2,540,916) Unchanged	€ 3,041,803 Balance sheet total 2024: € 3,041,803 ▼ 1% vs 2023 (€ 3,064,561) Unchanged	€ 3,009,185 Balance sheet total 2025: € 3,009,185 ▼ 1% vs 2024 (€ 3,041,803) Unchanged	▼ 1%

Key figures of GOVEMED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 October 2026.

What happened to GOVEMED?

What happened at GOVEMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 9, 2025 New annual accounts for financial year 2025: profit of € 48,302 (▲ 4% vs 2024). Source: NBB ↗
Sep 4, 2007 New establishment in Antwerpen. KBO
Sep 4, 2007 Start of the company according to the CBE. KBO

In short

From € 50,170 profit in 2022 to € 48,302 profit in 2025.

Paid € 61,431 in corporate taxes since 2022.

Best year ever: 2022, with € 50,170 profit.

Original PDFs at the National Bank ↗

A new publication or filing at GOVEMED? We notify you, reason included.

Follow GOVEMED

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Victor Gortz

GOVEMED

Apotheek Kroonplein 100%

Görtz Apotheek 99.8%

Behind GOVEMED is Victor Gortz. It owns 100% of Apotheek Kroonplein and 99.8% of Görtz Apotheek itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Victor Gortz

Director

Also active at: APOTHEEK GORTZ, APOTHEEK KROONPLEIN

Establishments

Establishment units

Physical locations of this company

Registered office

Kroonplein 46

2170 Antwerpen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0892.125.430

VAT number

BE 0892.125.430

Registered office

Kroonplein 46, 2170 Antwerpen

Names & denominations

GOVEMED

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

4 September 2007

Peppol

Active · Active since 1 Jan 2001

Contact

[email protected]

Activities · NACE

Overige zakelijke dienstverlening, neg

Overige zakelijke dienstverlening, n.e.g.

View on CBE Public ↗ Annual accounts (NBB) ↗

GOVEMED

Warning lights

Financials

What happened to GOVEMED?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions